Russia's biopharmaceutical industries are the heart of healthcare and medical system of Russia. The thing that after Russia's invasion of Ukraine and heavy sanctions that paralyzed Russia's money and banking system by banning access of SWIFT faced big financial problems.
Russia's Biopharmaceutical industries now facing big challenge for finance and supplying primer resources for pharmaceutical products.
Money and banking system sanctions, totally stop Russia's foreign trade and Russia's GDP failed by 2022. Economists predict that damaging to the Russia's economic infrastructures and exit of entrepreneurs and capital flight are big threaten against Russia's biopharmaceutical industries and this will be a threaten against social immunity against next pandemic and social medical problems.
The thing that in short term will threaten Kremlin political system existence and is a warning for the Russia's political and economical system. Medical security index under heaviest sanctions of west will fall down and it's a big risk for the Russia's healthcare programs.
No comments:
Post a Comment